Notes on Recurrent Urinary Tract Infections

Introduction to Recurrent Urinary Tract Infections (RUTI)

  • Urinary tract infection (UTI) is a common bacterial infection in women, affecting 20% of women aged 20–56 annually.

  • Approximately one in four women will experience a recurrence of UTI.

  • The average rate of acute cystitis is 0.5–0.7 episodes/year per individual, with 40–50% of women suffering from at least one UTI in their lifetime.

  • Recurrence Rates: 27% within 6–12 months, higher in catheterized individuals (< 60 days).

Definitions

  • Bacteriuria: Presence of bacteria in urine.

    • Symptomatic: 100 CFU/mL is diagnostic.

    • Asymptomatic: Requires 100,000 CFU/mL.

  • RUTI: Defined as three or more symptomatic UTIs within a 12-month period.

    • Re-infection vs Relapse:

    • Re-infection: New infection or same organism regrown >2 weeks post-treatment.

    • Relapse: Same bacterial strain from urinary tract within 2 weeks of treatment.

  • RUTIs due to re-infection are more prevalent (80% of cases).

Risk Factors

Young/Premenopausal Women
  • Sexual Intercourse: Strongly associated with RUTIs. Introduces uropathogens into the bladder mechanically (Foxman et al).

  • Contraceptive Use: Particularly with spermicides and diaphragms, altering vaginal flora in favor of uropathogens, increasing UTI risk (Fihn et al).

  • Antimicrobial Use: Disruption of normal flora can lead to reduced resistance to uropathogens, promoting persistent colonization by E. coli (Hooton et al).

  • Oestrogen Levels: Role is controversial; deficiency increases UTI risk in postmenopausal women, but excess estrogen can increase adherence of uropathogens (Hooton et al).

  • Genetics: Familial predisposition noted in cases of RUTI with increased incidence in non-secretors of ABO histo-blood group antigens.

  • Distance of Urethra from Anus: Shorter distances potentially increase risk, albeit this is modest (Hooton et al).

Postmenopausal Women
  • Divided into healthy vs. elderly institutionalized women, the latter being at higher risk.

  • Factors include oestrogen deficiency, previous UTIs, urogenital surgery, and incontinence (Raz and Stamm).

Complicated UTIs
  • Often involve multi-resistant pathogens; risk factors include urinary stasis conditions such as kidney stones or neurogenic bladder.

Bacteriology

  • Pathogens: Primarily E. coli (70–95% of cases), followed by Staphylococcus saprophyticus (5–20%), and less common pathogens like Proteus mirabilis and Klebsiella species.

  • Common strains recur due to re-infection from gut flora (Russo et al).

Mechanism of Infection

  • UTIs often begin with colonization of the vagina by enteric bacteria, such as E. coli.

  • Uropathogenic E. coli (UPEC) utilizes adhesins to attach to bladder epithelial cells and form biofilms which protect them from host defenses and antibiotics.

  • The repeated cycle of colonization, infection, and recurrence is central to RUTI development.

Clinical Presentation

  • Classic symptoms: Dysuria, frequency, urgency, and suprapubic discomfort. Upper tract infection may present with loin pain, haematuria, and fever.

  • Elderly patients may show generalized malaise or confusion.

Investigations

  • Urine Examination: Clean-catch sample; microscopy and culture are the gold standard for diagnosis.

  • Urinalysis: Dipstick tests may show nitrates/nitrites but have high false-negative rates.

  • Blood Tests: Useful if pyelonephritis or diabetes suspected.

  • Imaging: Ultrasound for upper tract infections, and cystourethroscopy for complications.

Management

  • Risk Factor Correction: Address contraception methods and manage incontinence in the elderly.

  • Antibiotic Therapy: Full course therapy followed by prophylactic strategies:

    • Long-term Prophylaxis: Administer low-dose antibiotics for 6–12 months.

    • Post-coital Prophylaxis: Immediate antibiotic dose after sexual intercourse.

    • Patient-initiated Therapy: Patients can start antibiotics at the first sign of symptoms.

  • Oestrogen Therapy: For postmenopausal women, may help restore normal flora (controversial).

  • Cranberry Juice: May reduce recurrent bacteriuria through various mechanisms, available anecdotal evidence supports its use.

Research Agenda

  • Focus on optimal durations of prophylaxis, genetics of susceptibility, and potential vaccine development for RUTI prevention.

Conclusion

  • RUTIs significantly affect women's health, necessitating a multifaceted approach for management including risk factor evaluation, proper diagnostics, and effective prevention strategies.